Case study

Implementing Risk-Based Quality Management in Pharma

Comprehensive exploration of Risk-Based Quality Management in the pharmaceutical industry, highlighting key service providers, regulatory hurdles, and the role of RBQM in pharma.

Implementing Risk-Based Quality Management in Pharma
  • Global
  • US
  • Europe
  • Pharma
  • CRO

CHALLENGE

Our client, a private equity firm in Europe, sought to gain a comprehensive understanding of the implementation of Risk-Based Quality Management (RBQM) strategies in the pharmaceutical industry. The focus was on identifying the key players, understanding the importance of these strategies, and recognizing the challenges involved, both regulatory and technical. The client aimed to explore the landscape from two perspectives: RBQM solution provider firms and pharma customers.

BTHT APPROACH

BTHT team strategically sourced experts with firsthand experience in both developing and utilizing RBQM services. We divided our search into two key areas of focus:

  1. Solution Provider Insights: We connected with seasoned professionals from leading RBQM service companies. This included former Senior Vice Presidents, Chief Commercial Officers, and Chief Operating Officers, as well as former Directors of eClinical Operations. These experts were equipped to provide an insider’s view on the capabilities, market positioning, and innovations of RBQM solutions.
  2. Pharma Perspectives: On the customer side, our team identified high-level executives from prominent pharmaceutical companies, such as Directors of Risk Management Strategy, Heads of Risk-Based Quality Management, Program Management Leads, and Clinical Operations Leads. These professionals shared their experiences with integrating RBQM strategies, their evaluation of external IT services providers, and the specific challenges they faced, particularly in compliance and technological adoption.

Our experts conducted detailed discussions that covered everything from the importance of RBQM in current pharmaceutical practices to predictions for future trends and innovations.

OUTCOME

The consultations provided the client with a comprehensive view of the RBQM market. They gained clarity on the role and impact of RBQM in enhancing quality and compliance within pharmaceutical operations. The insights gathered helped the client understand the competitive dynamics among service providers, identify critical regulatory and technical hurdles, and gauge the market's direction. Armed with this information, the client was well-prepared to consider strategic investments and partnerships, as well as to anticipate and mitigate potential challenges in implementing RBQM strategies.

Get in touch

Let's talk about your project

Reach our CEO Alexis Capelle directly or send us a message — we typically reply within one business day.